All News

2068 articles, sorted by publication time.

Biotechnology · global

Insilico and CMS Team Up Again as AI Drug Development Turns Toward CNS Diseases

From an anti-fibrotic drug entering late-stage clinical development to a new CNS collaboration, Insilico’s AI drug discovery narrative is being pulled back to a stricter question: can algorithms deliver drug candidates that experiments and clinical practice will recognize in the field of brain diseases, where penetration and validation are among the hardest challenges?

Biopharmaceuticals · global

FDA Declines to Clear Elevar Liver Cancer Combination Therapy, With Review Focused on Manufacturing Site

A new drug application in liver cancer failed to clear the U.S. regulatory threshold, with the reason pointing to the production side rather than clinical efficacy alone; this again shows that in the competitive field of advanced liver cancer treatment, whether a drug can reach the market often also depends on whether the supply chain can withstand inspection.

biology · global

Orviglance Faces FDA Hold-Up as Dispute Shifts From the Drug Itself to Image Reading

After Ascelia’s application for its liver MRI contrast agent received a complete response letter from the FDA, the latest explanation points the regulatory focus toward the clinical image-reading process; this leaves the company room for further dialogue, while also underscoring that in reviews of diagnostic drugs, how data are generated and interpreted is equally critical.